We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking ELVN? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EL

Enliven Therapeutics, Inc. (ELVN) short interest & options flow

NASDAQ

ELVN reports after the close today having gained 20% over the past month — a stock re-rating that has run well ahead of the broader small-cap biotech tape and sets a high bar for the print. The analyst community has been uniformly bullish in the run-up. Goldman Sachs lifted its target to $67 on July 21 while reiterating Buy — the most notable move from a bellwether firm. Stifel and…

Latest pulse29 Jun 2026

ELVN cost to borrow surges to 1.22%, up 127% in one week, as availability plummets to 1,812% of short interest.

$47.25+5.40% 1d+5.52% 1w+0.60% 1mClose: 4 Nov 2026
Short interest % of float
High
Live SI on ORTEX →
Cost to borrow
Rising
Live CTB on ORTEX →
Availability
High
Live availability on ORTEX →
Market cap
$3.47B
Next earnings
9 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 5 Nov 2026

ORTEX chart of Enliven Therapeutics, Inc. (ELVN) share price and short interest (% of free float), six months to November 4, 2026

Latest signals on ELVN

  • Cost to Borrow

    ELVN cost to borrow surges to 1.22%, up 127% in one week, as availability plummets to 1,812% of short interest.

ELVN news and analysis

RSS

No long-form analysis yet for ELVN. Pulse alerts and the live data picture are available on ORTEX.

Open ELVN on ORTEX →

Want the live picture for ELVN?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ELVN — free to start on ORTEX.

Sign up for free →Open ELVN on ORTEX